Europe & Central Asia (excluding high income) vs Slovakia: Treatment for hypertension, male

Europe & Central Asia (excluding high income)
41.5%
in 2019
Slovakia
58.5%
in 2019
Europe & Central Asia (excluding high income) rank
13th
Slovakia rank
11th

Treatment for hypertension, male over time

  • Europe & Central Asia (excluding high income)
  • Slovakia
2030405060199020042019

How they compare

Slovakia currently reports 58.5% against 41.5% in Europe & Central Asia (excluding high income), a difference of 17.0%.

That makes Slovakia's figure about 1.4 times Europe & Central Asia (excluding high income)'s.

Across all 30 years both countries report, Slovakia has been ahead every year.

Europe & Central Asia (excluding high income) ranks 13th and Slovakia ranks 11th of 43 groups.

Slovakia has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Europe & Central Asia (excluding high income) Slovakia Difference Ahead
1990s 19.9% 31.3% 11.4% Slovakia
2000s 29.4% 43.0% 13.6% Slovakia
2010s 38.5% 54.1% 15.6% Slovakia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment for hypertension, male, Europe & Central Asia (excluding high income) or Slovakia?
Slovakia, at 58.5% against 41.5% in Europe & Central Asia (excluding high income) as of 2019.
What is the difference in treatment for hypertension, male between Europe & Central Asia (excluding high income) and Slovakia?
17.0%, with Slovakia ahead.
How many years of comparable data are there for Europe & Central Asia (excluding high income) and Slovakia?
30 years are reported by both, from 1990 to 2019.
How do Europe & Central Asia (excluding high income) and Slovakia rank globally for treatment for hypertension, male?
Europe & Central Asia (excluding high income) ranks 13th and Slovakia ranks 11th of 43 groups.
Where does this data come from?
World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Europe & Central Asia (excluding high income) vs Slovakia: Treatment for hypertension, male. Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 19 September 2026, from https://health.statizoid.com/compare/treatment-for-hypertension-male-percent-of-male-adults-ages-30-79-with-hypertension/europe-and-central-asia-excluding-high-income/slovak-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-for-hypertension-male-percent-of-male-adults-ages-30-79-with-hypertension/europe-and-central-asia-excluding-high-income/slovak-republic/">Europe & Central Asia (excluding high income) vs Slovakia: Treatment for hypertension, male</a> — Statizoid

About this data

Indicator
Treatment for hypertension, male (% of male adults ages 30-79 with hypertension)
Unit
% of male adults ages 30-79 with hypertension
Source
World Health Organization's Global Health Observatory Data Repository
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 7,050 data points, 1990–2019
Last refreshed

Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.